New Drug Offers Hope for Rare Obesity, but Research Faces Uncertainty
A new drug, Vykat XR, has been approved to help manage hyperphagia in Prader-Willi syndrome, offering hope for improved quality of life, but broader obesity research faces challenges due to federal funding cuts, potentially hindering progress in understanding and treating various obesity causes.
